IRCT2013020412361N1已完成未知
The effect of riboflavin to prevent the migraine in 5-13 year-old children
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 13 years（—）
- 性别
- All
入选标准
- •5-13 year-old migraineous children according to ICHD II criteria who have minimally two moderate to severe migraine attacks monthly.
- •Exclusion criteria: Epilepsy or severe neurologic disorders ; Liver, kidney, GI, metabolic or cardiovascular disorders ; Use of migraine prophylactic drugs during the last month ; Incooperation of parents or patients ; Headache attacks less than twice per month ; Tension headache ; Mild migraine headache
排除标准
- 未提供
研究者
相似试验
撤回
不适用
Effects of oral riboflavin supplementation on the growth of Faecalibacterium prausnitzii and the impact on the gut microbiota: A randomized, double-blind, placebo-controlled human intervention trial.Healthy Intestinal MicrobiotaMicrobiota Gut HealthNL-OMON43887DSM Food Specialties105
已完成
不适用
Improvement of Migraine Severity and Frequency With Migraineguard ™HeadacheMigraineNCT04759040Herbacure Natural120
已完成
不适用
Preventive effect of aliskiren on migraine complicated with hypertension.JPRN-UMIN000006350Department of Neurology, School of Medicine, Keio University20
尚未招募
不适用
Treating with magnesium in migraine patients with magnesium defiencyCTRI/2020/05/025454Vinayaka missions medical college and hospital
招募中
2 期
The use of a Vitamin B nutraceutical to treat migraineMigraineACTRN12612001195842Griffith University400